Linked Life Data

8439785

Source:http://linkedlifedata.com/resource/pubmed/id/8439785

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1993-4-1
pubmed:abstractText
The decision whether to anticoagulate is a common dilemma when faced with a patient with atrial fibrillation. This article reviews the role of warfarin and antiplatelet agents and recommends a rational approach to the management of this condition.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0007-1064
pubmed:author
pubmed:issnType
Print
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
186-90
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
Benefits and risks of thrombolytic, anticoagulant and antiplatelet therapies in atrial fibrillation.
pubmed:affiliation
Cardiac Department, London Chest Hospital.
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't